QQ客服 官方微博 反馈留言

	The efficacy and safety of nivolumab, pembrolizumab, and atezolizumab in treatment of advanced non-small cell lung cancer
	Chen Rui[1]; Tao Yuquan[2]; Xu Xin[3]; Shan Liang[4]; Jiang Hongyuan[5]; Yin Qilei[6]; Pei Lingyan[7]; Cai Feng[8]; Ma Lifang[9]; Yu Yongchun[10]
刊名	Discovery medicine
	2018
卷号	26页码:155-166
ISSN号	1944-7930
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2167597
专题	上海大学
作者单位	1.[1]Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. 2.[2]Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. 3.[3]Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. 4.[4]Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. 5.[5]Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. 6.[6]Department of Clinical Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. 7.[7]Department of Clinical Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. 8.[8]Department of Clinical Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. 9.[9]Department of Clinical Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. 10.[10]Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China.
推荐引用方式 GB/T 7714	Chen Rui[1],Tao Yuquan[2],Xu Xin[3],et al. The efficacy and safety of nivolumab, pembrolizumab, and atezolizumab in treatment of advanced non-small cell lung cancer[J]. Discovery medicine,2018,26:155-166.
APA	Chen Rui[1].,Tao Yuquan[2].,Xu Xin[3].,Shan Liang[4].,Jiang Hongyuan[5].,...&Yu Yongchun[10].(2018).The efficacy and safety of nivolumab, pembrolizumab, and atezolizumab in treatment of advanced non-small cell lung cancer.Discovery medicine,26,155-166.
MLA	Chen Rui[1],et al."The efficacy and safety of nivolumab, pembrolizumab, and atezolizumab in treatment of advanced non-small cell lung cancer".Discovery medicine 26(2018):155-166.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。